Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 4/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 5/20 | 0.41 |
| ▸ | CA2 | P00918 | 5/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.41 |
| ▸ | HTR2B | P41595 | 2/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30309279 | 1.00 | TRPA1 (0.52) | TRPA1ATMALDH1A1GABRA1GABRB2 | |
| Water SCHEMBL27928522 | 0.98 | TRPA1 (0.50) | TRPA1ATMALDH1A1GABRA1GABRB2 | |
| SCHEMBL725385 | 0.85 | GABRA1 (0.52) | TRPA1ATMALDH1A1GABRA1GABRB2 | |
| SCHEMBL29558466 | 0.84 | TRPA1 (0.50) | TRPA1ATMALDH1A1GABRA1GABRB2 | |
| SCHEMBL17423984 | 0.82 | CYP1A2 (0.41) | TRPA1ATMALDH1A1GABRA1GABRB2 | |
| SCHEMBL9197954 | 0.82 | TRPA1 (0.48) | TRPA1ATMALDH1A1GABRA1GABRB2 | |
| SCHEMBL598366 | 0.82 | CA1 (0.50) | TRPA1ATMALDH1A1GABRA1GABRB2 | |
| Orthocresol SCHEMBL13729731 | 0.80 | GABRA1 (0.55) | TRPA1ATMALDH1A1GABRA1GABRB2 | |
| SCHEMBL6656127 | 0.79 | TRPA1 (0.50) | TRPA1ATMALDH1A1GABRA1GABRB2 | |
| SCHEMBL4932369 | 0.79 | GABRA1 (0.43) | TRPA1ATMALDH1A1GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 495 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115843953-A | Antibacterial composition and preparation method and application thereof | 珠海市自然之旅生物技术有限公司 | 2023-03-28 | — | — | CN | claimed |
| CN-111579712-A | Method for stably detecting moisture in chlorinated olefin | 常州新东化工发展有限公司 | 2020-08-25 | — | — | CN | claimed |
| EP-3166691-B1 | ORAL AND DENTAL CARE AND CLEANING PRODUCTS WITH ACTIVE AGENT DEPOSITION | HENKEL AG & CO KGAA (DE) | 2019-01-16 | — | — | EP | claimed |
| CN-107028784-A | A kind of oral care implement of fresh breath and preparation method thereof | 广州薇美姿实业有限公司 | 2017-08-11 | — | — | CN | claimed |
| EP-2552431-B1 | CARVACROL/THYMOL COMPOSITION FOR THE TREATMENT OF SALMONID RICKETTSIAL SEPTICEMIA AND INFECTIOUS SALMON ANEMIA | EWOS INNOVATION AS (NO) | 2017-06-14 | — | — | EP | claimed |
| EP-3166691-A1 | ORAL AND DENTAL CARE AND CLEANING PRODUCTS WITH ACTIVE AGENT DEPOSITION | Henkel AG & Co. KGaA (DE) | 2017-05-17 | — | — | EP | claimed |
| EP-3128837-A1 | A FORMULATION IN THE FORM OF A SUSPENSION FOR THE TREATMENT OF BLOOD-SUCKING PARASITE | VAKOS XT a.s. (CZ) | 2017-02-15 | — | — | EP | claimed |
| US-20160249608-A1 | ANTIMICROBIAL COMPOSITION AND TISSUE CONTAINING IT | SATISLOH AG (CH) | 2016-09-01 | — | — | US | claimed |
| EP-3048884-A1 | ANTIMICROBIAL COMPOSITION AND TISSUE CONTAINING IT | Satisloh AG (CH) | 2016-08-03 | — | — | EP | claimed |
| CN-105555133-A | Antimicrobial compositions and tissues containing same | SATISLOH AG | 2016-05-04 | — | — | CN | claimed |
| WO-2006067439-A1 | A METHOD OF DISINFECTING TEXTILE ARTICLES DURING LAUNDERING AND A LAUNDRY PREPARATION | QUILL INTERNATIONAL INDUSTRIES PLC (GB) | 2006-06-29 | — | — | WO | claimed |
| CN-1188035-C | Wax emulsion for treating seeds and its preparation and usage | CHINA PETROCHEMICAL CORP (CN) | 2005-02-09 | — | — | CN | claimed |
| CN-1491079-A | Antimicrobial compositions | — | 2004-04-21 | — | — | CN | claimed |
| EP-1347684-A1 | ANTI-MICROBIAL COMPOSITION | Byotrol LLC (GB) | 2003-10-01 | — | — | EP | claimed |
| US-20030031687-A1 | First compound having a high surface tension of 20-35 mN/m, second compound having a low surface tension of 8-14 mN/ m, a first anti-microbial agent and a polar solvent | BYOTROL LLC | 2003-02-13 | — | — | US | claimed |
| US-20020137631-A1 | Anti-microbial composition | FALDER STEPHEN BRIAN (GB) | 2002-09-26 | — | — | US | claimed |
| WO-2002062142-A1 | ANTI-MICROBIAL COMPOSITION | BYOTROL LLC (GB) | 2002-08-15 | — | — | WO | claimed |
| CN-1288661-A | Wax emulsion for treating seeds and its preparation and usage | CHINA PETROCHEMICAL CORP (CN) | 2001-03-28 | — | — | CN | claimed |
| US-4022911-A | Disinfectant composition comprising a quaternary ammonium compound, a phenol, and formaldehyde | DAMON CORPORATION (US) | 1977-05-10 | — | — | US | claimed |
| US-3968173-A | ALUMINUM SILICATE CATALYST | BAYER AKTIENGESELLSCHAFT (DT) | 1976-07-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160249608-A1 | ANTIMICROBIAL COMPOSITION AND TISSUE CONTAINING IT | ARG1, SIGMAR1, OGFRL1 | TRPA1 2289/4885ATM 4658/4885ALDH1A1 2747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.